siRNA treatment lowers triglycerides in individuals along with uncommon problem

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran lessened triglyceride amounts through 80% as well as reduced the danger of pancreatitis in people with constant chylomicronemia, along with or even without a genetic prognosis.